Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chimerism Monitoring after Allogeneic Hematopoietic Stem Cell Transplantation Using Quantitative Real-Time PCR of Biallelic Insertion/Deletion Polymorphisms 

Published byKelley Campbell Modified over 5 years ago

Similar presentations

Presentation on theme: "Chimerism Monitoring after Allogeneic Hematopoietic Stem Cell Transplantation Using Quantitative Real-Time PCR of Biallelic Insertion/Deletion Polymorphisms "— Presentation transcript:

1 Chimerism Monitoring after Allogeneic Hematopoietic Stem Cell Transplantation Using Quantitative Real-Time PCR of Biallelic Insertion/Deletion Polymorphisms  Seon Young Kim, Moon Hwan Jeong, Nare Park, Eunkyoung Ra, Hyunwoong Park, Soo Hyun Seo, Ji Yeon Kim, Moon-Woo Seong, Sung Sup Park  The Journal of Molecular Diagnostics  Volume 16, Issue 6, Pages (November 2014) DOI: /j.jmoldx Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

2 Figure 1 AlleleSEQR Chimerism Assay results for markers CA014, CA027, and CA030 using 250 ng (A and B) and 25 ng (C and D) of input DNA. These plots specifically show lower ranges of recipient DNA with 250 ng (B) and 25 ng (D) input DNA. The black diagonal lines represent summarized regression analysis results of all three markers. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

3 Figure 2 Comparison of recipient DNA percentages obtained between the AlleleSEQR Chimerism Assay and the STR (A and B) and the X/Y fluorescence in situ hybridization (FISH) method (C and D) in 175 samples after transplantation. Gray circles represent recipient DNA percentages; black lines, regression; and dashed lines, 95% CI of regression analysis. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

4 Figure 3 The recipient DNA percentages as measured by the AlleleSEQR Chimerism Assay and the STR method in acute leukemia patients who relapsed during the follow-up period (A) and those who did not relapse (B). Black arrows indicate when the relapse of acute leukemia was diagnosed; white triangles, the timing of bone marrow biopsy studies performed in remission status; black triangles, when bone marrow studies showed persistence of leukemic cells. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

5 Figure 4 Variation in CT values of reference and test samples among different specimens. In 14 samples in which two quantitative AlleleSEQR Chimerism Assays were performed, the difference in CT value between the first and second test was plotted for each patient. The CT values of the specific marker or positive control (CA999) show wide variations and moves in similar directions. The calculated ΔCT of the reference sample (CT informative marker of pre-HSCT sample − CT CA999 of pre-HSCT sample) has lower variability. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

6 Figure 5 Estimation of quantitative AlleleSEQR Chimerism Assay results using 1.03 as the estimated ΔCT value for the reference samples. A: Quantitative AlleleSEQR Chimerism Assay results, estimated AlleleSEQR Chimerism Assay results, and STR results for total samples. B: Results for samples with recipient DNA percentages ranging from 0% to 2%. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Download ppt "Chimerism Monitoring after Allogeneic Hematopoietic Stem Cell Transplantation Using Quantitative Real-Time PCR of Biallelic Insertion/Deletion Polymorphisms "

Similar presentations

Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.

Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.

CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Alexander A. Morley, Sue Latham, Michael J. Brisco, Pamela J

Alexander A. Morley, Sue Latham, Michael J. Brisco, Pamela J
Bone Marrow Transplant Engraftment Analysis with Loss of an Informative Allele  Steven A. Schichman, Pei Lin, Lori J. Gilbrech, Pamela S. Gray, Carla S.

Bone Marrow Transplant Engraftment Analysis with Loss of an Informative Allele  Steven A. Schichman, Pei Lin, Lori J. Gilbrech, Pamela S. Gray, Carla S.
Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms’ Tumor 1 Expression in Patients with Acute Myelogenous Leukemia after Allogeneic.

Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms’ Tumor 1 Expression in Patients with Acute Myelogenous Leukemia after Allogeneic.
Impact Of CMV Reactivation On Relapse In Patients With Acute Leukemia Who Received Allogeneic Stem Cell Transplantation In First Remission: Possible GVL.

Impact Of CMV Reactivation On Relapse In Patients With Acute Leukemia Who Received Allogeneic Stem Cell Transplantation In First Remission: Possible GVL.
Serial Measurement of WT1 Expression and Decrement Ratio Until Hematopoietic Cell Transplantation as a Marker of Residual Disease in Patients with Cytogenetically.

Serial Measurement of WT1 Expression and Decrement Ratio Until Hematopoietic Cell Transplantation as a Marker of Residual Disease in Patients with Cytogenetically.
Pre-Clinical Validation of a Novel, Highly Sensitive Assay to Detect PML-RARα mRNA Using Real-Time Reverse-Transcription Polymerase Chain Reaction  James.

Pre-Clinical Validation of a Novel, Highly Sensitive Assay to Detect PML-RARα mRNA Using Real-Time Reverse-Transcription Polymerase Chain Reaction  James.
Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,

Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma  Qiushi Wang, Xin Yang, Yong He, Qiang Ma, Li Lin,
Rapid Detection of the Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer for Analysis of Acquired Resistance Using Molecular Beacons 

Rapid Detection of the Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer for Analysis of Acquired Resistance Using Molecular Beacons 
Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies  Ulrike Bacher, Julie-An Talano, Michael.

Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies  Ulrike Bacher, Julie-An Talano, Michael.
Pilocytic Astrocytomas Have Telomere-Associated Promyelocytic Leukemia Bodies without Alternatively Lengthened Telomeres  Tania Slatter, Jennifer Gifford-Garner,

Pilocytic Astrocytomas Have Telomere-Associated Promyelocytic Leukemia Bodies without Alternatively Lengthened Telomeres  Tania Slatter, Jennifer Gifford-Garner,
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.

A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.
Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.

Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.
Separate Quality-Control Measures Are Necessary for Estimation of RNA and Methylated DNA from Formalin-Fixed, Paraffin-Embedded Specimens by Quantitative.

Separate Quality-Control Measures Are Necessary for Estimation of RNA and Methylated DNA from Formalin-Fixed, Paraffin-Embedded Specimens by Quantitative.
Diagnostic Application of an Extensive Gene Panel for Leber Congenital Amaurosis with Severe Genetic Heterogeneity  Moon-Woo Seong, Soo Hyun Seo, Young.

Diagnostic Application of an Extensive Gene Panel for Leber Congenital Amaurosis with Severe Genetic Heterogeneity  Moon-Woo Seong, Soo Hyun Seo, Young.
Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma  Esther M. van Wezel, Danny Zwijnenburg, Lily.

Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma  Esther M. van Wezel, Danny Zwijnenburg, Lily.
Da Eun Lee, Ji Hyae Lim, Min Hyoung Kim, So Yeon Park, Hyun Mee Ryu 

Da Eun Lee, Ji Hyae Lim, Min Hyoung Kim, So Yeon Park, Hyun Mee Ryu 
Establishment and Study of Different Real-Time Polymerase Chain Reaction Assays for the Quantification of Cells with Deletions of Chromosome 7  Elia Mattarucchi,

Establishment and Study of Different Real-Time Polymerase Chain Reaction Assays for the Quantification of Cells with Deletions of Chromosome 7  Elia Mattarucchi,
A DNA Real-Time Quantitative PCR Method Suitable for Routine Monitoring of Low Levels of Minimal Residual Disease in Chronic Myeloid Leukemia  Paul A.

A DNA Real-Time Quantitative PCR Method Suitable for Routine Monitoring of Low Levels of Minimal Residual Disease in Chronic Myeloid Leukemia  Paul A.

Similar presentations

Ads by Google